Propel Bio Management, LLC
Propel Bio Management, LLC reported 29 holdings worth US$191M as of Jun 30, 2026 (Form 13F)
As of Jun 30, 2026 · Filed Aug 13, 2026
Propel Bio Management, LLC reported 29 holdings worth US$191M as of Jun 30, 2026. Largest: Plains Gp Holdings, L.p., Achieve Life Sciences, Inc. and Corcept Therapeutics Incorporated. Filed Aug 13, 2026 (Form 13F).
- Holdings
- 29
- Value as reported
- US$191M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Plains Gp Holdings, L.p. | 1.27M | US$30.9M | 16.2% |
| Achieve Life Sciences, Inc. | 4.03M | US$26.3M | 13.8% |
| Corcept Therapeutics Incorporated | 136K | US$11.9M | 6.2% |
| Phathom Pharmaceuticals, Inc. | 1.05M | US$11.4M | 6.0% |
| Delcath Systems, Inc. | 871K | US$11M | 5.7% |
| Milestone Pharmaceuticals Inc. | 7.43M | US$9.96M | 5.2% |
| Kyverna Therapeutics, Inc. | 883K | US$7.87M | 4.1% |
| Artiva Biotherapeutics, Inc. | 696K | US$6.76M | 3.5% |
| Abeona Therapeutics Inc. | 983K | US$6.08M | 3.2% |
| Aquestive Therapeutics, Inc. | 1.44M | US$6M | 3.1% |
| Palisade Bio, Inc. | 2.58M | US$5.4M | 2.8% |
| Immunic, Inc. | 325K | US$5M | 2.6% |
| Inventiva Sa | 1.28M | US$4.84M | 2.5% |
| Sab Biotherapeutics, Inc. | 1.08M | US$4.2M | 2.2% |
| Orchestra Biomed Holdings, Inc. | 897K | US$3.87M | 2.0% |
| Celldex Therapeutics, Inc. | 104K | US$3.86M | 2.0% |
| Zevra Therapeutics, Inc. | 254K | US$3.64M | 1.9% |
| Ocular Therapeutix, Inc. | 358K | US$3.52M | 1.8% |
| 4d Molecular Therapeutics, Inc. | 253K | US$3.36M | 1.8% |
| Ovid Therapeutics Inc. | 1.12M | US$3M | 1.6% |
| Eyepoint, Inc. | 192K | US$2.74M | 1.4% |
| Upstream Bio, Inc. | 350K | US$2.42M | 1.3% |
| Leonabio, Inc. | 149K | US$1.37M | 0.72% |
| Maze Therapeutics, Inc. | 43,798 | US$1.31M | 0.68% |
| Corvus Pharmaceuticals, Inc. | 70,380 | US$1.05M | 0.55% |
| Sagimet Biosciences Inc. - Series A | 126K | US$973K | 0.51% |
| Connect Biopharma Holdings Limited | 0 | US$0 | 0.00% |
| Evommune, Inc. | 0 | US$0 | 0.00% |
| Kalaris Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Nuvation Bio Inc. | 0 | US$0 | 0.00% |
| Satellos Bioscience Inc | 0 | US$0 | 0.00% |
| Trevi Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Viridian Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Vor Biopharma Inc. | 0 | US$0 | 0.00% |
| Aldeyra Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Coherus Oncology, Inc. | 0 | US$0 | 0.00% |
Source
View original at SEC
Related